NCT06146335

Brief Summary

The purpose of this study is to compare the effect of two procedures - the Kono-S procedure and the side-to-side functional end to end anastomosis - on the microbiome (the bacteria that live in our gut) and on the intestinal immune system. The investigators are hypothesizing that there are differences in the microbiome environment and the immune environment between the two procedural groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 3, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

1.4 years

First QC Date

November 17, 2023

Last Update Submit

November 14, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes in composition of the microbiome between treatment groups

    Microbiome composition will be measured via an analysis of of 16S rRNA sequencing from tissue samples.

    At the time of the surgery

  • Changes in the immune cell environment between treatment groups

    Immune cell environment in the tissue will be measured by gene expression levels in the tissue sample via bulk RNA sequencing.

    3-6 month, 12-18 month and 60 month post-surgery endoscopy.

Study Arms (2)

Kono-S anastomosis (KSa)

EXPERIMENTAL

Randomized enrollment of preoperative patients undergoing surgical resection for Crohn's ileitis or ileocolitis

Procedure: Kono-S anastomosis (KSa)

side-to-side anastomosis (SSa)

ACTIVE COMPARATOR

Randomized enrollment of preoperative patients undergoing surgical resection for Crohn's ileitis or ileocolitis

Procedure: Side-to-side anastomosis (SSa)

Interventions

antimesenteric functional end-to-end handsewn anastomosis connecting small intestine and colon after surgery

Kono-S anastomosis (KSa)

side-to-side anastomosis connecting small intestine and colon after surgery

side-to-side anastomosis (SSa)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Crohn's ileitis/ileocolitis requiring surgical resection OR patients previously enrolled in the "Kono-S anastomosis versus side-to-side functional end anastomosis in the prevention of post-operative recurrence of Crohn's Disease (WC IRB #1303013645)" trial.
  • Patients age 18 years and older.
  • All phenotypes will be included: nonstricturing nonpenetrating (B1), stricturing (B2), and penetrating (B3) according to the Vienna classification.
  • Patients will be included regardless of preoperative medications (untreated, steroids, biologics)

You may not qualify if:

  • Patients under 18 years of age.
  • Pregnant patients.
  • Patient does not speak English
  • Patients that may need a different surgical procedure as per the surgeon at the time of intraoperative evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medical Center

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Fabrizio Michelassi, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2023

First Posted

November 24, 2023

Study Start

January 3, 2024

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

November 18, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations